Called aptamers.

Aptamers give unique therapeutic advantages A novel class of drugs composed of one strands of DNA or RNA, called aptamers, can bind protein targets with a high strength and specificity and so are currently in clinical advancement as treatments for a broad selection of common diseases, as explained in a thorough critique article published online ahead of print in Oligonucleotides. Aptamer therapeutics presently in clinical development focus on applications and diseases such as macular degeneration, coronary artery bypass graft operation, and different types of cancers read more .